Maple syrup urine disease and the blocked metabolic step
Locate the BCKD bottleneck, then use that model to explain recognition, confirmation, brain effects, acute metabolic control and long-term nutrition.
A sweet smell can start the hypothesis, but a changing amino-acid pool explains the illness. Follow its inputs, blocked exit and competing brain transport before deciding what to test and treat.
Find the blocked commitment step
Core relationship. BCKD is the shared irreversible exit. When it cannot keep pace, reversible BCAT lets both BCAAs and their corresponding ketoacids accumulate upstream.
A newborn fed normally for two days, then becomes lethargic and develops a sweet odor. Which arrow in branched-chain amino acid metabolism must fail to make both amino acids and ketoacids accumulate?
Leucine, isoleucine and valine are essential branched-chain amino acids (BCAAs). Branched-chain aminotransferase (BCAT) exchanges their amino groups with alpha-ketoglutarate, producing glutamate and, respectively, alpha-ketoisocaproate (KIC), alpha-keto-beta-methylvalerate (KMV) and alpha-ketoisovalerate (KIV). This reaction is reversible. high ketoacid can drive amino acid re-formation. The multienzyme branched-chain alpha-ketoacid dehydrogenase complex (BCKD) then commits each ketoacid to irreversible oxidative decarboxylation, yielding an acyl-CoA and CO2. In MSUD, insufficient BCKD activity backs up both sides of BCAT; a single blocked arrow explains the elevated plasma BCAAs and urinary branched-chain ketoacids. Transamination is prominent in skeletal muscle, while subsequent oxidation is distributed across tissues including liver. It is misleading to call liver the site of most initial BCAA catabolism. Pathway [1]Tissue distribution [2]
Leucine ⇄ KIC
Isoleucine ⇄ KMV
Valine ⇄ KIV
Each reversible arrow uses BCAT ↓ All three ketoacids converge
BCKD oxidation impaired The shared irreversible step cannot keep pace.
↑ Amino-acid and ketoacid pools rise ↓ Flux toward later carbon fates falls
Original three-lane comparison, not a molecular stoichiometry chart. BCKD yields intermediate acyl-CoAs first; listed carbon fates arise through later reactions. Mechanism [1]Carbon fates [2]
Trace each lane. leucine is ketogenic, ending in acetyl-CoA and acetoacetate; valine is glucogenic through succinyl-CoA; isoleucine contributes acetyl-CoA and succinyl-CoA. These are eventual carbon fates, not three products made directly by BCKD. A damaged common step suppresses those routes while aromatic sweet odor can emerge from abnormal metabolites in cerumen or urine; odor alone is neither necessary nor sufficient to diagnose MSUD. If KIC rises during fasting despite little oral leucine, ask whether muscle protein breakdown and reversible BCAT can refill the plasma leucine pool rather than concluding the diet is the only input.
Case 1
Need a nudge?
Compare the three parent amino acids with the detected ketoacid. Which shared reaction lies between those pools?
Show answer and explanations for case 1
A. BCAT transamination of leucine (Why this does not fit)
What makes this option worth considering?
BCAT produces KIC.
What does the paired evidence add?
kIC is already present in urine, demonstrating that transamination occurred
Complete explanation
BCAT produces KIC. The supplied evidence instead shows that kIC is already present in urine, demonstrating that transamination occurred.
B. BCKD oxidative decarboxylation of branched ketoacids (Best answer)
What makes this option worth considering?
The common downstream complex consumes KIC.
What does the paired evidence add?
Accumulation of both parents and KIC fits impaired oxidation after transamination.
Complete explanation
The common downstream complex consumes KIC. In this case, Accumulation of both parents and KIC fits impaired oxidation after transamination. The supplied evidence favors this answer. accumulation of both parents and KIC fits impaired oxidation after transamination.
C. Isovaleryl-CoA dehydrogenation (Why this does not fit)
What makes this option worth considering?
A leucine downstream enzyme can cause neonatal illness.
What does the paired evidence add?
the simultaneous isoleucine and valine elevations localize to their shared earlier step
Complete explanation
A leucine downstream enzyme can cause neonatal illness. The supplied evidence instead shows that the simultaneous isoleucine and valine elevations localize to their shared earlier step.
D. Propionyl-CoA carboxylation (Why this does not fit)
What makes this option worth considering?
Valine and isoleucine converge on propionyl-CoA.
What does the paired evidence add?
leucine and KIC accumulation puts the block upstream of this later branch
Complete explanation
Valine and isoleucine converge on propionyl-CoA. The supplied evidence instead shows that leucine and KIC accumulation puts the block upstream of this later branch.
E. Phenylalanine hydroxylation (Why this does not fit)
What makes this option worth considering?
Another amino-acid disorder presents after newborn screening.
What does the paired evidence add?
the measured excess is three BCAAs and KIC rather than phenylalanine
Complete explanation
Another amino-acid disorder presents after newborn screening. The supplied evidence instead shows that the measured excess is three BCAAs and KIC rather than phenylalanine.
Takeaway. BCAT makes the ketoacids; BCKD normally oxidatively decarboxylates all three. Both substrate classes rise when the second step fails.
Distinguish a shared cofactor from a shared defect
Core relationship. BCAT and BCKD are different reactions with different cofactors. A thiamine response shows a phenotype under treatment, not a unique mutant subunit.
BCAT uses pyridoxal phosphate, derived from vitamin B6. That transamination cofactor is distinct from the TPP needed for BCKD decarboxylation.
Why does a thiamine trial make biochemical sense but fail to identify a particular mutant subunit? BCKD resembles pyruvate dehydrogenase (PDH) and alpha-ketoglutarate dehydrogenase. their E1 chemistry needs thiamine pyrophosphate (TPP); the complex also uses lipoamide, CoA, FAD and NAD+. Cofactor architecture [4] The mnemonic “Tender Loving Care For Nancy” can retrieve these five, but the chemistry matters more than its letters. E1 decarboxylates, E2 transfers the acyl group, and E3 regenerates oxidized lipoamide. Complex architecture [1]
Compare a patient whose plasma BCAAs improve during a supervised thiamine trial with one who does not. Response documents a phenotype under those conditions, not certain TPP-binding-site genotype; published thiamine-responsive cases include E2/DBT variants. Do not postpone nutrition or crisis treatment while testing response. Biallelic BCKDHA (E1-alpha), BCKDHB (E1-beta) or DBT (E2) variants cause the usual MSUD spectrum. DLD encodes shared E3. its deficiency can also impair PDH and alpha-ketoglutarate dehydrogenase, with lactate elevation, neurologic or hepatic disease beyond the BCAA pattern. Leucinosis accompanied by persistent lactic acidosis or liver dysfunction should prompt a wider differential and molecular workup, not an automatic label of a thiamine-responsive E1 mutation. Phenotypes [1]
Why does a response to thiamine not identify the mutated subunit?
A supervised response measures the phenotype. It does not uniquely distinguish E1 variants from other residual-activity complexes, including reported DBT variants.
Explain why a plasma number is not the entire brain story
Core relationship. Plasma leucine reflects exposure, not a complete severity meter. Neurologic injury reflects transporter competition plus ketoacid and energy effects, so examination and trajectory remain part of interpretation.
In a child with rapidly worsening ataxia, what does a high circulating leucine level tell you, and what does it not tell you? Large neutral amino acids share transport across the blood-brain barrier through LAT1. Excess leucine competes with phenylalanine, tyrosine, tryptophan and other substrates. KIC and other ketoacids contribute toxicity and disturbed cerebral energy and neurotransmitter metabolism; mechanisms overlap, so leucine alone is not a complete neurotoxicity explanation. Brain edema and encephalopathy can progress to seizures and coma. A single concentration cannot serve as a universal injury threshold or substitute for examination and trajectory. Brain mechanisms [2]
Blood leucine rises Tyrosine, tryptophan and phenylalanine share entry.
Brain amino-acid imbalance Neurotransmitter precursors become less available.
Parallel KIC-associated harm Not shown as LAT1 transport ↓ Disturbed energy and neurotransmitter metabolism
Both processes contribute to dysfunction. No single injury threshold is implied.
Original conceptual gate; arrow widths do not quantify measured transport or injury. KIC contributes through routes not depicted as a LAT1 substrate. LAT1 and brain biochemistry [2]
Check mental status, serial amino acids and other metabolic derangements while arranging urgent metabolic care; MRI may support a crisis with symmetric diffusion abnormalities but a normal or nonspecific scan does not exclude MSUD or defer treatment. Lowering plasma leucine reduces exposure but does not erase prior injury or guarantee normal neurodevelopment. A child with stable peripheral values after transplantation still merits cognitive, psychiatric and neurologic follow-up because brain cells retain the inherited defect. The evidence for particular neurotransmitter pathways is evolving rather than a bedside diagnostic assay. CNS review [2]
What can excess leucine change even when aromatic amino acids are not elevated?
It can compete with their entry through LAT1, changing their relative availability within the brain.
Recognize the newborn and the child who was well yesterday
Core relationship. Presentation follows metabolic load versus disposal capacity. A patient can look well while input fits residual BCKD activity and decompensate when feeding or catabolism raises BCAA flux.
A baby appears well at birth, then after feeding becomes irritable, feeds poorly, vomits and develops alternating hypotonia, abnormal posturing, apnea or seizures. Why does the apparently normal first day not reassure? Maternal-placental exchange before birth and the changing postnatal protein load can delay the classic presentation; symptomatic deterioration often occurs in the first week. Maple-like odor of cerumen or urine is a helpful finding but may be missed. Untreated encephalopathy is an emergency. Clinical spectrum [1]
An older child with intermittent MSUD may grow and develop normally and have near-normal amino acids when well, then decompensate during fever, fasting, surgery or a high-protein challenge. Residual BCKD activity is not “normal enzyme”; its limited capacity may suffice only in a lower-load state. Intermediate disease may bring chronic poor growth or developmental symptoms rather than a single dramatic crisis. A newborn screen can miss milder or early-collected cases and a pending result never overrules an ill infant. Screen-positive infant action [5] Treat unexplained encephalopathy as an emergency while obtaining plasma quantitative amino acids, glucose, blood gas, electrolytes, ketones, lactate, ammonia and urine organic acids as clinically indicated. Evaluate sepsis and other treatable emergencies in parallel. Waiting for an odor, stereotyped movements or a screening callback can cost the interval in which catabolism is reversible. In a known patient who becomes ill despite excellent dietary adherence, identify endogenous protein breakdown rather than presuming a secret high-protein meal. Presentation [1]
Why can a child become ill after years of normal well-state amino acids?
Residual disposal can handle ordinary input but become overwhelmed by the increased protein breakdown of illness.
Separate a screening signal from confirmation
Core relationship. A newborn screen detects a combined isobaric signal, not a final diagnosis. Confirmation separates the amino acids and matches the pattern to the clinical state.
The dried-blood-spot report says “Leu/Ile elevated.” Does it specify leucine? Routine tandem mass spectrometry cannot reliably separate isobars leucine, isoleucine, alloisoleucine and hydroxyproline by mass alone. Hydroxyprolinemia can therefore cause a screen-positive signal. The laboratory may use second-tier chromatographic separation, but confirmatory quantitative plasma amino acids, including resolved alloisoleucine, and urine organic acids are central. Branched-chain ketoacids support pathway blockage; a qualitative urine DNPH ketoacid reaction is only an adjunct and not a specific diagnosis. Screen limitations [1]
A symptomatic infant with elevated BCAAs and alloisoleucine above the assay’s clinically meaningful threshold (commonly greater than 5 micromol/L in an untreated person) strongly supports MSUD. Alloisoleucine evidence [3] Interpret the value with age, treatment, assay and laboratory reference interval; do not say alloisoleucine “appears nowhere else” or that any detectable trace proves MSUD. Request the lab’s separation method and repeat/confirm when results conflict with clinical suspicion. Molecular testing can establish the subunit and support family testing, but do not delay stabilization pending sequencing. An isolated isobaric screen is not confirmation, while a normal screen when well does not exclude intermittent disease. Contrast PKU (phenylalanine elevation and phenylalanine hydroxylase/BH4 axis), isolated hydroxyprolinemia (screen isobar), other organic acidemias, sepsis and urea-cycle disorders; ammonia, ketones, acidosis, specific amino acids and urine acids help discriminate, not smell alone. Biochemical workup [1]
Case 4
Need a nudge?
Compare the separated analytes with their intervals. Does that explain the poor feeding?
Show answer and explanations for case 4
A. Classic BCKD deficiency despite normal separated BCAAs (Why this does not fit)
What makes this option worth considering?
A positive screen raises concern for MSUD.
What does the paired evidence add?
separated leucine/isoleucine are not elevated and alloisoleucine is undetected
Complete explanation
A positive screen raises concern for MSUD. The supplied evidence instead shows that separated leucine/isoleucine are not elevated and alloisoleucine is undetected.
B. BCAT deficiency causing selective ketoacid excess (Why this does not fit)
What makes this option worth considering?
BCAT is the adjacent upstream step.
What does the paired evidence add?
the screen is accounted for by measured hydroxyproline, not ketoacids
Complete explanation
BCAT is the adjacent upstream step. The supplied evidence instead shows that the screen is accounted for by measured hydroxyproline, not ketoacids.
C. E3 deficiency causing lactic acidosis (Why this does not fit)
What makes this option worth considering?
E3 can produce an MSUD-like screen.
What does the paired evidence add?
the only measured excess is hydroxyproline, with no BCAA excess
Complete explanation
E3 can produce an MSUD-like screen. The supplied evidence instead shows that the only measured excess is hydroxyproline, with no BCAA excess.
D. Hydroxyproline accounts for the screen signal (Best answer)
What makes this option worth considering?
The combined mass signal cannot identify its constituent analyte.
What does the paired evidence add?
Chromatography identifies hydroxyproline as the excess, not biochemical confirmation of MSUD.
Complete explanation
The combined mass signal cannot identify its constituent analyte. Chromatography identifies hydroxyproline as the excess, not biochemical confirmation of MSUD; the infant's poor feeding still needs prompt assessment.
E. Thiamine response accounts for the screen signal (Why this does not fit)
What makes this option worth considering?
A treatment response can alter BCAA concentrations.
What does the paired evidence add?
But these assays do not establish a response phenotype.
Complete explanation
A treatment response can alter BCAA concentrations, but these assays do not establish a response phenotype. Measured hydroxyproline explains the combined screen flag.
Takeaway. Chromatography attributes this screen flag to hydroxyproline rather than elevated BCAAs. Promptly assess the infant's existing poor feeding and evaluate other neonatal emergencies; the analyte result does not explain the symptom.
Treat the two inputs and the clearance problem together
Core relationship. Acute control has to reduce new BCAA input and improve removal. Dietary restriction addresses only one input because illness can release leucine from the patient's own protein.
A child with MSUD vomits for a day and stops eating protein, yet plasma leucine climbs. Where did it come from? Fasting, infection and stress accelerate endogenous muscle-protein breakdown. The patient's own protein is an input of all three BCAAs. A temporary reduction of intact protein intake limits one input but cannot stop that internal supply. Sufficient calories, BCAA-free medical amino acids and carefully titrated insulin when indicated support protein synthesis and suppress catabolism; glucose and electrolyte monitoring matter. Restriction without calories can worsen the crisis. Acute nutrition [1]
Dietary protein One input ↓
Muscle proteolysis Endogenous input ↓
Circulating BCAA pool Input exceeding disposal makes this pool grow.
↓ Complementary routes out
Incorporation into protein Energy and balanced amino acids support anabolism.
Extracorporeal removal Dialysis adds direct clearance when indicated.
BCKD disposal remains limited Nutrition also suppresses muscle proteolysis at the input.
Original qualitative pool model; arrows represent routes, not measured rates or a prescribing calculator. Acute management [1]
In severe encephalopathy, rapidly rising leucine, cerebral edema or failure to improve, consult a metabolic center and intensive care for hemodialysis or continuous kidney replacement/hemofiltration alongside, not after, anti-catabolic nutrition and monitoring. Choice and timing depend on condition, trend, vascular access and local expertise; no rigid 1500 micromol/L trigger applies to every patient. Manage cerebral edema, fluid and sodium carefully and treat the precipitant. Reintroduce age-appropriate essential BCAAs under specialist guidance rather than withholding all protein indefinitely. Dialysis can lower blood levels rapidly but cannot prevent rebound from continuing proteolysis. An insulin infusion without adequate calories, glucose checks and amino acid supply is not a self-contained cure. Acute management [1]
Case 6
Need a nudge?
What does neurologic deterioration despite current support imply about the remaining pool?
Show answer and explanations for case 6
A. Continue the current anabolic regimen and reassess neurologic status before adding clearance (Why this does not fit)
What makes this option worth considering?
Anticatabolic nutrition remains necessary.
What does the paired evidence add?
But worsening obtundation and edema despite that support show that waiting on the same regimen alone is not enough
Complete explanation
Anticatabolic nutrition remains necessary, but worsening obtundation and edema despite that support show that waiting on the same regimen alone is not enough.
B. Add a supervised thiamine trial while continuing support and defer extracorporeal clearance (Why this does not fit)
What makes this option worth considering?
Thiamine-responsive phenotypes exist.
What does the paired evidence add?
But a response trial should not delay rapid removal when neurologic deterioration is already progressing
Complete explanation
Thiamine-responsive phenotypes exist, but a response trial should not delay rapid removal when neurologic deterioration is already progressing.
C. Add hemodialysis or continuous hemofiltration while continuing anabolic support (Best answer)
Calories and medical amino acids should continue because clearance does not stop ongoing endogenous input
Complete explanation
Progressive encephalopathy and cerebral edema despite prompt anticatabolic treatment justify specialist-directed rapid extracorporeal leucine removal. Calories and medical amino acids should continue because clearance does not stop ongoing endogenous input.
D. Increase BCAA-free amino acids and reduce dextrose while waiting for a biochemical trend (Why this does not fit)
What makes this option worth considering?
Amino acids support anabolism.
What does the paired evidence add?
But reducing necessary energy can worsen catabolism and this plan does not directly address the current neurologic deterioration
Complete explanation
Amino acids support anabolism, but reducing necessary energy can worsen catabolism and this plan does not directly address the current neurologic deterioration.
E. Resume measured intact protein immediately to stimulate protein synthesis before considering clearance (Why this does not fit)
What makes this option worth considering?
Protein synthesis ultimately requires essential BCAAs.
What does the paired evidence add?
But adding intact protein during severe active hyperleucinemia can increase substrate load rather than provide rapid clearance
Complete explanation
Protein synthesis ultimately requires essential BCAAs, but adding intact protein during severe active hyperleucinemia can increase substrate load rather than provide rapid clearance.
Takeaway. Progressive encephalopathy or edema despite anticatabolic treatment warrants urgent specialist-directed extracorporeal clearance while anabolic support continues; no universal numeric trigger is required.
Preserve growth and support life beyond the crisis
Core relationship. BCAAs are essential, so long-term care balances enough intake for growth against a limited oxidation pathway. Crisis restriction must transition back to measured nutrition.
If leucine is harmful in excess, why not eliminate every BCAA permanently? Leucine, isoleucine and valine are essential. human cells cannot synthesize their carbon skeletons. A specialist-guided plan limits intact dietary protein and uses BCAA-free medical food plus measured BCAAs to support growth, protein synthesis and repair. Isoleucine or valine deficiency can cause poor growth and skin changes even while leucine is controlled. Plasma amino acids, nutritional adequacy, growth and development guide adjustments; requirements change with illness, pregnancy and age. Nutrition [1]
A child's leucine falls but rash and faltering growth appear with low isoleucine and valine. Reassess full nutrition rather than congratulating the low leucine alone. Equip families with an individualized sick-day plan, emergency letter and rapid access to a metabolic team; rehearse what to do during vomiting or fever, and arrange coordinated transition to adult care. Monitor neurodevelopment, school functioning and mental health without assuming a normal plasma sample equals normal brain function. Excess restriction causes deficiency and may provoke catabolism; recurrent crises and treatment burdens affect quality of life. At adulthood or during pregnancy, revisit leucine tolerance and care access rather than using a fixed childhood prescription. Longitudinal care [1]CNS outcomes [2]
Transplantation can introduce functional hepatic BCKD and markedly improve whole-body leucine handling, often liberalizing diet and preventing many crises. It does not transfer the gene to inherited brain cells, reverse established injury, or remove immunosuppression and graft risks. The donor liver's effective systemic contribution does not prove liver normally performs a majority of all BCAA catabolism. Discuss benefits and risks through an experienced team, and continue neurologic follow-up. Transplant and brain [2]Clinical management [1]
Usual BCKDHA, BCKDHB and DBT disease is autosomal recessive. If both parents carry a pathogenic variant in the same disease gene, each pregnancy independently has a 25% affected, 50% carrier and 25% unaffected noncarrier chance. Offer genetic counseling and targeted familial testing, including reproductive options; do not assign those fractions to an unverified family without establishing the molecular diagnosis and parental variants. Inheritance [1]
Why replace low isoleucine and valine while limiting excessive leucine?
All three are essential. Balanced supplies support protein synthesis; excessive restriction creates deficiency and can worsen catabolism.
Apply the causal model to clinical cases
These original educational cases use illustrative laboratory data. Reference intervals are supplied within the cases and are not universal clinical cutoffs. Three checks are placed beside related teaching; the remaining cases follow below. Independent practice starts here. Use the vignette first. Open Need a nudge? at any time for a reasoning prompt, or open the full explanations when you want the worked answer.
Case 2
Need a nudge?
Use the two assay directions separately. what is formed, and what fails to be consumed?
Show answer and explanations for case 2
A. Leucine falls; KIC falls (Why this does not fit)
What makes this option worth considering?
Increased clearance could lower both.
What does the paired evidence add?
complete leucine oxidation is nearly absent, not accelerated
Complete explanation
Increased clearance could lower both. The supplied evidence instead shows that complete leucine oxidation is nearly absent, not accelerated.
B. Leucine rises; KIC falls (Why this does not fit)
What makes this option worth considering?
Failure of transamination could spare leucine.
What does the paired evidence add?
the assay directly demonstrates preserved ketoacid formation
Complete explanation
Failure of transamination could spare leucine. The supplied evidence instead shows that the assay directly demonstrates preserved ketoacid formation.
C. Leucine falls; KIC rises (Why this does not fit)
What makes this option worth considering?
KIC might be trapped downstream.
What does the paired evidence add?
unoxidized leucine also backs up through reversible transamination
Complete explanation
KIC might be trapped downstream. The supplied evidence instead shows that unoxidized leucine also backs up through reversible transamination.
D. Leucine rises; KIC rises (Best answer)
What makes this option worth considering?
BCAT still makes KIC while BCKD cannot consume it.
What does the paired evidence add?
The two assay results imply accumulation on both sides of the reversible first step.
Complete explanation
BCAT still makes KIC while BCKD cannot consume it. In this case, The two assay results imply accumulation on both sides of the reversible first step. The supplied evidence favors this answer. the two assay results imply accumulation on both sides of the reversible first step.
E. Leucine unchanged; KIC falls (Why this does not fit)
What makes this option worth considering?
Residual clearance could preserve concentrations.
What does the paired evidence add?
oxidation is only 0.7% of control while KIC formation continues
Complete explanation
Residual clearance could preserve concentrations. The supplied evidence instead shows that oxidation is only 0.7% of control while KIC formation continues.
Takeaway. A retained BCAT step and nearly absent BCKD flux predict elevation of leucine and alpha-ketoisocaproate (KIC).
Which test identifies the constituent of the combined mass signal while the infant is evaluated?
Show answer and explanations for case 3
A. Repeat the first-tier spot today while arranging clinical assessment (Why this does not fit)
What makes this option worth considering?
Same-day assessment is warranted.
What does the paired evidence add?
But repeating an unresolved mass signal cannot distinguish hydroxyproline from BCAAs
Complete explanation
Same-day assessment is warranted, but repeating an unresolved mass signal cannot distinguish hydroxyproline from BCAAs.
B. Separate plasma amino acids including alloisoleucine while assessing the infant (Best answer)
What makes this option worth considering?
Poor feeding requires prompt assessment regardless of the screen's specificity.
What does the paired evidence add?
Quantitative separation identifies the analytes and tests for the characteristic BCAA/alloisoleucine pattern
Complete explanation
Poor feeding requires prompt assessment regardless of the screen's specificity. Quantitative separation identifies the analytes and tests for the characteristic BCAA/alloisoleucine pattern.
C. Measure urine organic acids while assessing the infant (Why this does not fit)
What makes this option worth considering?
Urinary branched ketoacids can support a pathway block and the infant needs assessment.
What does the paired evidence add?
But urine acids alone do not resolve which isobar generated this screen signal
Complete explanation
Urinary branched ketoacids can support a pathway block and the infant needs assessment, but urine acids alone do not resolve which isobar generated this screen signal.
D. Obtain a bedside blood gas and ketones while assessing the infant (Why this does not fit)
What makes this option worth considering?
These assess acute metabolic illness.
What does the paired evidence add?
But neither assigns the elevated combined screen signal to a specific amino acid or hydroxyproline
Complete explanation
These assess acute metabolic illness, but neither assigns the elevated combined screen signal to a specific amino acid or hydroxyproline.
E. Order a BCKD gene panel while assessing the infant (Why this does not fit)
What makes this option worth considering?
Molecular testing can establish a cause later.
What does the paired evidence add?
But the screen is not gene-specific and sequencing does not promptly resolve the measured analyte
Complete explanation
Molecular testing can establish a cause later, but the screen is not gene-specific and sequencing does not promptly resolve the measured analyte.
Takeaway. The first-tier signal may combine leucine, isoleucine, alloisoleucine and hydroxyproline; quantitative separated plasma amino acids provide prompt confirmation. A symptomatic infant needs immediate metabolic evaluation while testing proceeds.
Contrast the well specimen with the illness specimen. What changed in substrate supply?
Show answer and explanations for case 5
A. Limited BCKD reserve with illness-driven proteolysis (Best answer)
What makes this option worth considering?
A near-normal well-state value can reflect residual disposal capacity.
What does the paired evidence add?
Influenza raises endogenous BCAA input through proteolysis, allowing substrate load to exceed that limited reserve
Complete explanation
A near-normal well-state value can reflect residual disposal capacity. Influenza raises endogenous BCAA input through proteolysis, allowing substrate load to exceed that limited reserve.
B. Normal BCKD reserve with transient reduction in renal leucine clearance (Why this does not fit)
What makes this option worth considering?
Reduced renal clearance could raise a plasma concentration.
What does the paired evidence add?
But it does not explain the stress-linked pattern expected from a shared oxidative BCAA bottleneck or the large substrate surge during catabolism
Complete explanation
Reduced renal clearance could raise a plasma concentration, but it does not explain the stress-linked pattern expected from a shared oxidative BCAA bottleneck or the large substrate surge during catabolism.
C. Limited BCKD reserve with reduced proteolysis during influenza (Why this does not fit)
What makes this option worth considering?
Limited reserve could fit the well-state result.
What does the paired evidence add?
But reduced proteolysis would lower endogenous BCAA input rather than explain the marked illness-associated rise
Complete explanation
Limited reserve could fit the well-state result, but reduced proteolysis would lower endogenous BCAA input rather than explain the marked illness-associated rise.
D. Normal BCKD reserve with increased intestinal BCAA absorption during poor intake (Why this does not fit)
What makes this option worth considering?
A dietary load could raise leucine.
What does the paired evidence add?
But three days of influenza with vomiting makes increased intestinal input a poor fit compared with endogenous protein breakdown
Complete explanation
A dietary load could raise leucine, but three days of influenza with vomiting makes increased intestinal input a poor fit compared with endogenous protein breakdown.
E. Reduced BCAT flux with preserved BCKD oxidation (Why this does not fit)
What makes this option worth considering?
Lower transamination can alter ketoacid formation.
What does the paired evidence add?
But it does not explain a stress-unmasked failure of shared oxidative disposal while well-state concentrations remain near normal
Complete explanation
Lower transamination can alter ketoacid formation, but it does not explain a stress-unmasked failure of shared oxidative disposal while well-state concentrations remain near normal.
Takeaway. Intermittent MSUD can have near-normal baseline concentrations because residual BCKD reserve handles ordinary flux; illness-driven proteolysis can overwhelm that reserve.
Account for both the plasma and urine trends during the interval without intact protein.
Show answer and explanations for case 7
A. More proteolysis feeds reversible transamination, exceeding limited oxidation (Best answer)
What makes this option worth considering?
Illness and poor intake favor endogenous protein breakdown.
What does the paired evidence add?
Released BCAAs enter reversible BCAT while limited BCKD cannot clear the resulting ketoacids, so both pools can rise
Complete explanation
Illness and poor intake favor endogenous protein breakdown. Released BCAAs enter reversible BCAT while limited BCKD cannot clear the resulting ketoacids, so both pools can rise.
B. Less renal excretion retains leucine and its downstream acyl-CoAs (Why this does not fit)
What makes this option worth considering?
Renal handling can alter measured metabolites.
What does the paired evidence add?
But the paired BCAA and branched-ketoacid rise after fasting is better explained by endogenous input upstream of impaired oxidation
Complete explanation
Renal handling can alter measured metabolites, but the paired BCAA and branched-ketoacid rise after fasting is better explained by endogenous input upstream of impaired oxidation.
C. More dietary BCAA absorption feeds transamination despite fasting (Why this does not fit)
What makes this option worth considering?
A protein load can increase both pools.
What does the paired evidence add?
But the reported interval has no intact-protein intake.
Complete explanation
A protein load can increase both pools, but the reported interval has no intact-protein intake. Internal protein release remains available.
D. Less BCAT flux retains leucine while increasing ketoacid formation (Why this does not fit)
What makes this option worth considering?
Reduced transamination might raise parent BCAA.
What does the paired evidence add?
But it would not itself increase formation of the measured branched ketoacids
Complete explanation
Reduced transamination might raise parent BCAA, but it would not itself increase formation of the measured branched ketoacids.
E. More BCKD oxidation clears ketoacids while leucine enters plasma (Why this does not fit)
What makes this option worth considering?
Greater BCKD oxidation would consume ketoacids.
What does the paired evidence add?
The reported urine trend instead shows their increase during illness
Complete explanation
Greater BCKD oxidation would consume ketoacids. The reported urine trend instead shows their increase during illness.
Takeaway. During illness, endogenous protein breakdown releases essential BCAAs even when dietary protein is withheld; calories and anabolic protein support matter.
Which measured substrates are deficient despite an acceptable leucine value?
Show answer and explanations for case 8
A. Increase intact dietary protein until isoleucine and valine normalize (Why this does not fit)
What makes this option worth considering?
Intact protein supplies the deficient amino acids.
What does the paired evidence add?
But it also delivers additional leucine without controlling the individual BCAA doses
Complete explanation
Intact protein supplies the deficient amino acids, but it also delivers additional leucine without controlling the individual BCAA doses.
B. Add measured isoleucine and valine while maintaining the leucine target and serial amino-acid monitoring (Best answer)
What makes this option worth considering?
Isoleucine and valine are both below the supplied intervals while leucine is already within its interval.
What does the paired evidence add?
Targeted replacement corrects the demonstrated deficiencies without an uncontrolled leucine load
Complete explanation
Isoleucine and valine are both below the supplied intervals while leucine is already within its interval. Targeted replacement corrects the demonstrated deficiencies without an uncontrolled leucine load.
C. Increase leucine while reducing isoleucine and valine to keep total BCAA intake unchanged (Why this does not fit)
What makes this option worth considering?
The measured deficiencies are isoleucine and valine.
What does the paired evidence add?
Shifting the same total BCAA dose toward leucine would worsen the demonstrated imbalance rather than replace the deficient substrates
Complete explanation
The measured deficiencies are isoleucine and valine. Shifting the same total BCAA dose toward leucine would worsen the demonstrated imbalance rather than replace the deficient substrates.
D. Increase calories alone while leaving the amino-acid prescription unchanged (Why this does not fit)
What makes this option worth considering?
Adequate energy can reduce catabolism.
What does the paired evidence add?
But calories alone do not replace the two measured essential amino-acid deficits
Complete explanation
Adequate energy can reduce catabolism, but calories alone do not replace the two measured essential amino-acid deficits.
E. Reduce BCAA-free medical amino acids and replace the calories with fat (Why this does not fit)
What makes this option worth considering?
Fat can provide energy.
What does the paired evidence add?
But reducing non-BCAA amino-acid substrate does not correct the specific isoleucine and valine deficiencies or support balanced protein synthesis
Complete explanation
Fat can provide energy, but reducing non-BCAA amino-acid substrate does not correct the specific isoleucine and valine deficiencies or support balanced protein synthesis.
Takeaway. BCAA restriction must remain balanced. measured isoleucine and valine replacement can correct deficiency while leucine exposure stays individually monitored.
Which abnormalities extend beyond a defect confined to one branched-substrate complex?
Show answer and explanations for case 9
A. BCKD E1-alpha alone (Why this does not fit)
What makes this option worth considering?
E1 loss explains alloisoleucine.
What does the paired evidence add?
lactate and alpha-ketoglutarate with hepatic dysfunction implicate additional complexes
Complete explanation
E1 loss explains alloisoleucine. The supplied evidence instead shows that lactate and alpha-ketoglutarate with hepatic dysfunction implicate additional complexes.
B. BCAT alone (Why this does not fit)
What makes this option worth considering?
BCAT precedes BCKD.
What does the paired evidence add?
the abundant branched ketoacids show transamination continues
Complete explanation
BCAT precedes BCKD. The supplied evidence instead shows that the abundant branched ketoacids show transamination continues.
C. Dihydrolipoamide dehydrogenase (E3) (Best answer)
What makes this option worth considering?
E3 is shared by BCKD, PDH and alpha-KGDH.
What does the paired evidence add?
The combined branched-ketoacid, lactate and alpha-ketoglutarate pattern tracks all three.
Complete explanation
E3 is shared by BCKD, PDH and alpha-KGDH. In this case, The combined branched-ketoacid, lactate and alpha-ketoglutarate pattern tracks all three. The supplied evidence favors this answer. the combined branched-ketoacid, lactate and alpha-ketoglutarate pattern tracks all three.
D. Phenylalanine hydroxylase (Why this does not fit)
What makes this option worth considering?
An amino-acid disorder can cause neurologic disease.
What does the paired evidence add?
the reported elevations center on branched ketoacids and PDH-linked lactate
Complete explanation
An amino-acid disorder can cause neurologic disease. The supplied evidence instead shows that the reported elevations center on branched ketoacids and PDH-linked lactate.
E. Isovaleryl-CoA dehydrogenase (Why this does not fit)
What makes this option worth considering?
A leucine-pathway disorder can cause acidosis.
What does the paired evidence add?
alloisoleucine and metabolites of the other BCAAs point to the shared complex
Complete explanation
A leucine-pathway disorder can cause acidosis. The supplied evidence instead shows that alloisoleucine and metabolites of the other BCAAs point to the shared complex.
Takeaway. DLD-encoded E3 participates in three oxidative decarboxylase complexes and can add lactic acidosis and hepatic findings to an MSUD-like profile.
Compare both analyte classes across matched on and off periods. Which flux change fits?
Show answer and explanations for case 10
A. Increased BCKD-pathway flux under thiamine is supported (Best answer)
What makes this option worth considering?
Both upstream amino acid and ketoacid pools fall with a reproducible on/off response at matched intake.
What does the paired evidence add?
This supports functional pathway improvement, not proof of a specific variant or permanent restoration
Complete explanation
Both upstream amino acid and ketoacid pools fall with a reproducible on/off response at matched intake. This supports functional pathway improvement, not proof of a specific variant or permanent restoration.
B. Reduced BCAA intake under thiamine is the main explanation (Why this does not fit)
What makes this option worth considering?
Less substrate could lower both pools.
What does the paired evidence add?
But dietary intake was matched across the periods
Complete explanation
Less substrate could lower both pools, but dietary intake was matched across the periods.
C. Suppressed BCAT transamination alone explains both falls (Why this does not fit)
What makes this option worth considering?
Less transamination can lower ketoacids.
What does the paired evidence add?
But parent BCAAs would tend to accumulate rather than fall together at matched intake
Complete explanation
Less transamination can lower ketoacids, but parent BCAAs would tend to accumulate rather than fall together at matched intake.
D. A primary PDH response explains the BCAA and ketoacid changes (Why this does not fit)
What makes this option worth considering?
PDH also uses thiamine.
What does the paired evidence add?
But unchanged pyruvate/lactate and concordant branched-substrate changes favor the BCKD pathway
Complete explanation
PDH also uses thiamine, but unchanged pyruvate/lactate and concordant branched-substrate changes favor the BCKD pathway.
E. Permanent BCKD restoration explains the off-treatment rebound (Why this does not fit)
What makes this option worth considering?
The rebound specifically argues against a permanent correction.
What does the paired evidence add?
responsiveness remains conditional on treatment
Complete explanation
The rebound specifically argues against a permanent correction; responsiveness remains conditional on treatment.
Takeaway. A controlled biochemical and dietary-tolerance response supports a responsive phenotype; genotype and long-term requirements require separate assessment.
What changes during fasting even when the recent well-state panel is normal?
Show answer and explanations for case 11
A. Provide glucose-containing IV calories with planned metabolic monitoring during the fast (Best answer)
What makes this option worth considering?
The current normal panel reflects a low-stress state, not unlimited reserve.
What does the paired evidence add?
Planned carbohydrate energy reduces proteolysis while serial monitoring detects a stress-related rise early
Complete explanation
The current normal panel reflects a low-stress state, not unlimited reserve. Planned carbohydrate energy reduces proteolysis while serial monitoring detects a stress-related rise early.
B. Provide BCAA-free amino acids without carbohydrate and monitor leucine after surgery (Why this does not fit)
What makes this option worth considering?
Medical amino acids can support synthesis.
What does the paired evidence add?
But withholding energy during a prolonged fast still promotes proteolysis and endogenous BCAA release
Complete explanation
Medical amino acids can support synthesis, but withholding energy during a prolonged fast still promotes proteolysis and endogenous BCAA release.
C. Use routine noncaloric maintenance fluid and check plasma BCAAs only if symptoms appear (Why this does not fit)
What makes this option worth considering?
Routine fluid prevents dehydration but not fasting catabolism.
What does the paired evidence add?
waiting for symptoms misses the predictable substrate-load problem
Complete explanation
Routine fluid prevents dehydration but not fasting catabolism; waiting for symptoms misses the predictable substrate-load problem.
D. Arrange prophylactic extracorporeal clearance while otherwise using the usual overnight fast (Why this does not fit)
What makes this option worth considering?
Dialysis can remove leucine in severe crisis.
What does the paired evidence add?
But no current toxic rise is present and it does not substitute for preventing fasting-induced catabolism
Complete explanation
Dialysis can remove leucine in severe crisis, but no current toxic rise is present and it does not substitute for preventing fasting-induced catabolism.
E. Allow unrestricted high-protein intake until induction, then use routine noncaloric fluid (Why this does not fit)
What makes this option worth considering?
A preoperative protein load adds extra BCAA substrate before anesthesia.
What does the paired evidence add?
Following it with a calorie-free fast then promotes catabolic release instead of controlling total flux
Complete explanation
A preoperative protein load adds extra BCAA substrate before anesthesia. Following it with a calorie-free fast then promotes catabolic release instead of controlling total flux.
Takeaway. Proactive carbohydrate energy and individualized monitoring reduce catabolic BCAA release; routine fasting without support is risky.
Which tracer reaches a glucogenic entry, and which reaches ketone-related products?
Show answer and explanations for case 12
A. Valine to acetyl-CoA; leucine to succinyl-CoA (Why this does not fit)
What makes this option worth considering?
A shared oxidative gate can obscure later divergence.
What does the paired evidence add?
The leucine tracer lacks the glucogenic succinyl-CoA signal
Complete explanation
A shared oxidative gate can obscure later divergence. The leucine tracer lacks the glucogenic succinyl-CoA signal.
B. Valine to succinyl-CoA; leucine to acetyl-CoA plus acetoacetate (Best answer)
What makes this option worth considering?
Residual flux permits both tracers past the shared step.
What does the paired evidence add?
The valine signal fits glucogenic succinyl-CoA, whereas leucine's ketone-related products fit acetyl-CoA and acetoacetate
Complete explanation
Residual flux permits both tracers past the shared step. The valine signal fits glucogenic succinyl-CoA, whereas leucine's ketone-related products fit acetyl-CoA and acetoacetate.
C. Valine to acetoacetate; leucine to succinyl-CoA (Why this does not fit)
What makes this option worth considering?
The two labels have distinct destinations.
What does the paired evidence add?
This pair assigns the glucogenic signal to leucine rather than valine
Complete explanation
The two labels have distinct destinations. This pair assigns the glucogenic signal to leucine rather than valine.
D. Valine to succinyl-CoA; leucine to succinyl-CoA (Why this does not fit)
What makes this option worth considering?
A common BCKD step need not give identical terminal fates.
What does the paired evidence add?
the leucine tracer does not appear in the stated TCA entry product
Complete explanation
A common BCKD step need not give identical terminal fates; the leucine tracer does not appear in the stated TCA entry product.
E. Valine to acetyl-CoA; leucine to acetyl-CoA (Why this does not fit)
What makes this option worth considering?
The leucine branch is ketogenic.
What does the paired evidence add?
But this pair omits the observed valine glucogenic entry and leucine acetoacetate
Complete explanation
The leucine branch is ketogenic, but this pair omits the observed valine glucogenic entry and leucine acetoacetate.
Takeaway. The common BCKD step precedes divergent downstream routes. valine is glucogenic via succinyl-CoA, while leucine yields acetyl-CoA and acetoacetate.
Separate what a high plasma value implies about transport from other possible injury routes.
Show answer and explanations for case 13
A. Greater cerebral entry of tyrosine with reduced leucine entry (Why this does not fit)
What makes this option worth considering?
Competition at LAT1 is relevant.
What does the paired evidence add?
markedly high leucine preferentially occupies shared transport capacity
Complete explanation
Competition at LAT1 is relevant. The supplied evidence instead shows that markedly high leucine preferentially occupies shared transport capacity.
B. Selective loss of ketone oxidation with no amino-acid transport change (Why this does not fit)
What makes this option worth considering?
Leucine is ketogenic downstream.
What does the paired evidence add?
the case concerns severe circulating leucine and cerebral edema
Complete explanation
Leucine is ketogenic downstream. The supplied evidence instead shows that the case concerns severe circulating leucine and cerebral edema.
C. Impaired ammonia clearance with secondary brain injury (Why this does not fit)
What makes this option worth considering?
Hyperammonemia can cause encephalopathy.
What does the paired evidence add?
But an isolated ammonia-clearance defect does not unify the established BCKD deficiency, sharp leucine rise, and known branched-chain metabolic block
Complete explanation
Hyperammonemia can cause encephalopathy, but an isolated ammonia-clearance defect does not unify the established BCKD deficiency, sharp leucine rise, and known branched-chain metabolic block.
D. Leucine transport competition plus ketoacid-associated injury (Best answer)
What makes this option worth considering?
High leucine competes with other large neutral amino acids at LAT1.
What does the paired evidence add?
BCKD dysfunction also permits ketoacid accumulation that may contribute to injury.
Complete explanation
High leucine competes with other large neutral amino acids at LAT1. BCKD dysfunction also permits ketoacid accumulation that may contribute to injury; the measured trajectory and swelling fit a multifactorial mechanism.
E. Primary vascular injury with secondary amino-acid changes (Why this does not fit)
What makes this option worth considering?
Vascular injury can produce swelling.
What does the paired evidence add?
But the established BCKD defect and sharp leucine rise directly support a metabolic contribution.
Complete explanation
Vascular injury can produce swelling, but the established BCKD defect and sharp leucine rise directly support a metabolic contribution. The supplied imaging does not establish or exclude an infarct distribution.
Takeaway. Leucine competes at LAT1 and disrupts cerebral amino-acid homeostasis; KIC also contributes to neurotoxicity. Edema is multifactorial, not a single proven osmotic mechanism.
Keep the infant’s symptoms separate from the uncertainty of a first-tier screen.
Show answer and explanations for case 14
A. Begin urgent neonatal evaluation for sepsis and other emergencies but defer metabolic treatment until separated amino acids return (Why this does not fit)
What makes this option worth considering?
Parallel evaluation for other emergencies is appropriate.
What does the paired evidence add?
But poor feeding and lethargy make it unsafe to withhold anticatabolic support while the metabolic diagnosis remains unresolved
Complete explanation
Parallel evaluation for other emergencies is appropriate, but poor feeding and lethargy make it unsafe to withhold anticatabolic support while the metabolic diagnosis remains unresolved.
B. Obtain urgent metabolic consultation, start anticatabolic calories, and send separated plasma amino acids plus urine organic acids (Best answer)
What makes this option worth considering?
The first-tier signal is not diagnostic.
What does the paired evidence add?
But the infant is symptomatic.
Complete explanation
The first-tier signal is not diagnostic, but the infant is symptomatic. Immediate stabilization and confirmatory biochemical testing can proceed together.
C. Obtain urgent metabolic consultation and give intact protein feeds while awaiting plasma confirmation (Why this does not fit)
What makes this option worth considering?
Preventing catabolism matters.
What does the paired evidence add?
But intact protein adds leucine before the suspected oxidative bottleneck is clarified.
Complete explanation
Preventing catabolism matters, but intact protein adds leucine before the suspected oxidative bottleneck is clarified; energy can be supplied without that uncontrolled substrate load.
D. Transfer urgently but repeat only the dried-blood-spot screen before beginning metabolic support (Why this does not fit)
What makes this option worth considering?
Urgent transfer fits the poor feeding and lethargy.
What does the paired evidence add?
Repeating the same unresolved screening signal does not replace quantitative confirmation or justify delaying anticatabolic support
Complete explanation
Urgent transfer fits the poor feeding and lethargy. Repeating the same unresolved screening signal does not replace quantitative confirmation or justify delaying anticatabolic support.
E. Start glucose support now but defer plasma and urine confirmation until a molecular panel identifies a BCKD gene (Why this does not fit)
What makes this option worth considering?
Glucose support is useful.
What does the paired evidence add?
But molecular testing is slower and does not replace prompt biochemical confirmation of the active metabolic state
Complete explanation
Glucose support is useful, but molecular testing is slower and does not replace prompt biochemical confirmation of the active metabolic state.
Takeaway. A positive screen is not a diagnosis, but a symptomatic neonate merits urgent assessment and prevention of catabolism while confirmation proceeds.
Other amino acids supply substrates for protein synthesis. Reduced proteolysis lowers endogenous nitrogen loss, while measured leucine can be incorporated into new protein despite unchanged BCKD.
B. Lower nitrogen loss with direct restoration of KIC oxidation (Why this does not fit)
What makes this option worth considering?
Improved anabolism can reduce nitrogen loss.
What does the paired evidence add?
But amino-acid provision does not repair the oxidative enzyme defect
Complete explanation
Improved anabolism can reduce nitrogen loss, but amino-acid provision does not repair the oxidative enzyme defect.
C. Higher nitrogen loss with greater incorporation of leucine into protein (Why this does not fit)
What makes this option worth considering?
Leucine incorporation is a possible effect.
What does the paired evidence add?
But rising nitrogen loss would suggest continuing breakdown rather than successful anabolism
Complete explanation
Leucine incorporation is a possible effect, but rising nitrogen loss would suggest continuing breakdown rather than successful anabolism.
D. Lower nitrogen loss with complete loss of future BCAA requirements (Why this does not fit)
What makes this option worth considering?
Reduced proteolysis is plausible.
What does the paired evidence add?
essential BCAAs still require measured replacement for growth
Complete explanation
Reduced proteolysis is plausible; essential BCAAs still require measured replacement for growth.
E. Unchanged nitrogen loss with direct extracorporeal leucine removal (Why this does not fit)
What makes this option worth considering?
Dialysis can remove circulating leucine.
What does the paired evidence add?
But the added formula supplies building blocks rather than extracorporeal clearance
Complete explanation
Dialysis can remove circulating leucine, but the added formula supplies building blocks rather than extracorporeal clearance.
Takeaway. Energy plus BCAA-free amino acids promotes endogenous protein synthesis and counters proteolysis; prolonged total protein starvation is not the goal.
Trace each elevated parent amino acid one reversible step downstream.
Show answer and explanations for case 16
A. Alpha-ketoisocaproate, alpha-ketoisovalerate, and alpha-keto-beta-methylvalerate (Best answer)
What makes this option worth considering?
The three elevated parent BCAAs can still undergo BCAT transamination.
What does the paired evidence add?
Failure of their shared downstream oxidation allows the corresponding branched ketoacids to accumulate and appear in urine
Complete explanation
The three elevated parent BCAAs can still undergo BCAT transamination. Failure of their shared downstream oxidation allows the corresponding branched ketoacids to accumulate and appear in urine.
B. Phenylpyruvate, phenyllactate, and phenylacetate (Why this does not fit)
What makes this option worth considering?
Phenylpyruvate, phenyllactate, and phenylacetate fit excess phenylalanine metabolism.
What does the paired evidence add?
They do not explain the supplied elevation of all three BCAAs and alloisoleucine
Complete explanation
Phenylpyruvate, phenyllactate, and phenylacetate fit excess phenylalanine metabolism. They do not explain the supplied elevation of all three BCAAs and alloisoleucine.
C. Methylmalonate, methylcitrate, and 3-hydroxypropionate (Why this does not fit)
What makes this option worth considering?
Methylmalonate, methylcitrate, and 3-hydroxypropionate point toward propionyl-CoA or methylmalonyl-CoA handling.
What does the paired evidence add?
They do not fit a shared block immediately after transamination of all three BCAAs
Complete explanation
Methylmalonate, methylcitrate, and 3-hydroxypropionate point toward propionyl-CoA or methylmalonyl-CoA handling. They do not fit a shared block immediately after transamination of all three BCAAs.
D. Isovalerate, 3-hydroxyisovalerate, and isovalerylglycine (Why this does not fit)
What makes this option worth considering?
Isovalerate, 3-hydroxyisovalerate, and isovalerylglycine emphasize a later leucine-specific branch.
What does the paired evidence add?
They do not explain the simultaneous isoleucine and valine pattern
Complete explanation
Isovalerate, 3-hydroxyisovalerate, and isovalerylglycine emphasize a later leucine-specific branch. They do not explain the simultaneous isoleucine and valine pattern.
E. Lactate, pyruvate, and alpha-ketoglutarate (Why this does not fit)
What makes this option worth considering?
Those metabolites can suggest broader dehydrogenase dysfunction.
What does the paired evidence add?
But they do not replace the expected branched ketoacids produced from the three elevated BCAAs
Complete explanation
Those metabolites can suggest broader dehydrogenase dysfunction, but they do not replace the expected branched ketoacids produced from the three elevated BCAAs.
Takeaway. Leucine, valine and isoleucine respectively yield KIC, KIV and KMV before BCKD; the ketoacids accumulate when oxidation fails.
Compare substrate flux at early collection with the later illness-associated pattern.
Show answer and explanations for case 17
A. Residual BCKD activity plus low early substrate flux can keep the neonatal signal below cutoff (Best answer)
What makes this option worth considering?
Partial oxidative capacity may handle the lower substrate load of the early specimen.
What does the paired evidence add?
Later illness-driven proteolysis can exceed that reserve and reveal the characteristic BCAA/alloisoleucine pattern
Complete explanation
Partial oxidative capacity may handle the lower substrate load of the early specimen. Later illness-driven proteolysis can exceed that reserve and reveal the characteristic BCAA/alloisoleucine pattern.
B. Hydroxyproline coelution can selectively lower the combined BCAA signal below cutoff (Why this does not fit)
What makes this option worth considering?
Hydroxyproline can contribute to a false-positive unresolved combined signal.
What does the paired evidence add?
It does not selectively suppress a true BCAA signal below cutoff and therefore does not reconcile the later stress-associated pattern
Complete explanation
Hydroxyproline can contribute to a false-positive unresolved combined signal. It does not selectively suppress a true BCAA signal below cutoff and therefore does not reconcile the later stress-associated pattern.
C. A below-cutoff neonatal result excludes inherited BCKD disease if the specimen was collected before discharge (Why this does not fit)
What makes this option worth considering?
Timing and residual activity affect sensitivity.
What does the paired evidence add?
a later reproducible stress-associated BCAA/alloisoleucine pattern is not erased by an earlier below-cutoff result
Complete explanation
Timing and residual activity affect sensitivity; a later reproducible stress-associated BCAA/alloisoleucine pattern is not erased by an earlier below-cutoff result.
D. The patient most likely acquired a pathogenic BCKD variant after the newborn period (Why this does not fit)
What makes this option worth considering?
Late clinical expression does not require an acquired variant.
What does the paired evidence add?
inherited partial activity can remain clinically quiet until substrate flux rises
Complete explanation
Late clinical expression does not require an acquired variant; inherited partial activity can remain clinically quiet until substrate flux rises.
E. The newborn report proves alloisoleucine was individually resolved and normal at 24 hours (Why this does not fit)
What makes this option worth considering?
A program cutoff documents only the reported screening result.
What does the paired evidence add?
It does not establish the assay's exact separation method or prove that alloisoleucine was individually quantified and normal
Complete explanation
A program cutoff documents only the reported screening result. It does not establish the assay's exact separation method or prove that alloisoleucine was individually quantified and normal.
Takeaway. Negative neonatal screening does not exclude milder intermittent MSUD; test interpretation depends on specimen timing, assay and metabolic state.
Which tissue gains activity, and which tissues keep their inherited genotype?
Show answer and explanations for case 18
A. Donor hepatic BCKD adds systemic clearance; prior CNS injury and recipient extrahepatic genotype can remain (Best answer)
What makes this option worth considering?
Stable circulating leucine can follow added functional hepatic BCKD capacity.
What does the paired evidence add?
Transplant does not rewrite recipient tissues or guarantee reversal of established neurologic injury
Complete explanation
Stable circulating leucine can follow added functional hepatic BCKD capacity. Transplant does not rewrite recipient tissues or guarantee reversal of established neurologic injury.
B. Donor hepatic BCKD is secreted into brain cells; prior CNS injury should therefore reverse (Why this does not fit)
What makes this option worth considering?
The metabolic benefit is substantial.
What does the paired evidence add?
But BCKD is an intracellular mitochondrial complex and prior neurologic injury need not reverse
Complete explanation
The metabolic benefit is substantial, but BCKD is an intracellular mitochondrial complex and prior neurologic injury need not reverse.
C. Immunosuppression activates recipient muscle BCKD; the donor liver mainly prevents rejection (Why this does not fit)
What makes this option worth considering?
Immunosuppression protects the graft.
What does the paired evidence add?
it does not repair the inherited BCKD variants in recipient muscle
Complete explanation
Immunosuppression protects the graft; it does not repair the inherited BCKD variants in recipient muscle.
D. Diet liberalization shows the inherited genotype is cured; long-term graft risks are no longer relevant (Why this does not fit)
What makes this option worth considering?
Diet liberalization reflects improved systemic metabolic control from the donor liver.
What does the paired evidence add?
It does not establish germline correction, and graft plus immunosuppression risks remain
Complete explanation
Diet liberalization reflects improved systemic metabolic control from the donor liver. It does not establish germline correction, and graft plus immunosuppression risks remain.
E. Stable leucine proves extrahepatic tissues are genetically corrected; recurrence risk in offspring falls (Why this does not fit)
What makes this option worth considering?
Somatic organ transplantation can improve systemic leucine handling.
What does the paired evidence add?
It does not alter the recipient's germline or genetically correct extrahepatic tissues, so offspring recurrence risk is unchanged
Complete explanation
Somatic organ transplantation can improve systemic leucine handling. It does not alter the recipient's germline or genetically correct extrahepatic tissues, so offspring recurrence risk is unchanged.
Takeaway. A functional liver contributes enough BCKD activity for metabolic stability, but transplantation is not germline correction, does not guarantee reversal of preexisting deficits and introduces graft risks.
First list the unaffected genotypes, then condition the carrier count on that group.
Show answer and explanations for case 19
A. 0% (Why this does not fit)
What makes this option worth considering?
Unaffected can mean no variants.
What does the paired evidence add?
two heterozygous offspring are unaffected carriers in the four-outcome cross
Complete explanation
Unaffected can mean no variants. The supplied evidence instead shows that two heterozygous offspring are unaffected carriers in the four-outcome cross.
B. 25% (Why this does not fit)
What makes this option worth considering?
One-quarter is a familiar recessive risk.
What does the paired evidence add?
that is the unconditional affected fraction, not carrier conditional on unaffected
Complete explanation
One-quarter is a familiar recessive risk. The supplied evidence instead shows that that is the unconditional affected fraction, not carrier conditional on unaffected.
C. 50% (Why this does not fit)
What makes this option worth considering?
Half of all offspring are carriers.
What does the paired evidence add?
conditioning on unaffected excludes the affected quarter, leaving two of three
Complete explanation
Half of all offspring are carriers. The supplied evidence instead shows that conditioning on unaffected excludes the affected quarter, leaving two of three.
D. 66.7% (Best answer)
What makes this option worth considering?
Two of the three unaffected genotypic outcomes are carriers.
What does the paired evidence add?
Conditioning on unaffected status excludes the affected quarter, giving two-thirds, approximately 66.7%
Complete explanation
Two of the three unaffected genotypic outcomes are carriers. Conditioning on unaffected status excludes the affected quarter, giving two-thirds, approximately 66.7%.
E. 75% (Why this does not fit)
What makes this option worth considering?
Three-quarters of children are unaffected.
What does the paired evidence add?
that fraction includes both noncarriers and carriers
Complete explanation
Three-quarters of children are unaffected. The supplied evidence instead shows that that fraction includes both noncarriers and carriers.
Takeaway. Among unaffected offspring of two carriers, two of three genotypic outcomes are carriers; each pregnancy independently has a one-quarter affected probability.
What is the risk of prolonged deprivation, and what must guide the return of essential intake?
Show answer and explanations for case 20
A. Continue BCAA-free nutrition until leucine first enters range, then restart the previous intact-protein prescription in one step (Why this does not fit)
What makes this option worth considering?
A target concentration matters.
What does the paired evidence add?
But an abrupt return does not account for changing illness state, serial trends, or individual tolerance
Complete explanation
A target concentration matters, but an abrupt return does not account for changing illness state, serial trends, or individual tolerance.
B. Resume unrestricted intact protein as soon as the leucine trend turns downward (Why this does not fit)
What makes this option worth considering?
A falling leucine trend is reassuring but is only one part of readiness for reintroduction.
What does the paired evidence add?
The absolute concentration and clinical state still matter, and unrestricted protein can rapidly increase substrate load
Complete explanation
A falling leucine trend is reassuring but is only one part of readiness for reintroduction. The absolute concentration and clinical state still matter, and unrestricted protein can rapidly increase substrate load.
C. Maintain calories but postpone all amino-acid reintroduction for another week regardless of serial levels (Why this does not fit)
What makes this option worth considering?
Calories suppress catabolism.
What does the paired evidence add?
But prolonged amino-acid deprivation limits protein synthesis and can itself promote breakdown or deficiency
Complete explanation
Calories suppress catabolism, but prolonged amino-acid deprivation limits protein synthesis and can itself promote breakdown or deficiency.
D. Continue measured valine and isoleucine but keep leucine intake at zero until discharge (Why this does not fit)
What makes this option worth considering?
Valine and isoleucine can require replacement.
What does the paired evidence add?
But leucine is also essential.
Complete explanation
Valine and isoleucine can require replacement, but leucine is also essential; indefinite zero intake is not the long-term goal.
E. Titrate intact-protein and BCAA reintroduction using serial amino acids, clinical status, and metabolic-team targets (Best answer)
What makes this option worth considering?
The falling trend allows consideration of reintroduction.
What does the paired evidence add?
But timing and amount must integrate the absolute concentrations, ongoing catabolic state, and the need to avoid essential-amino-acid deprivation
Complete explanation
The falling trend allows consideration of reintroduction, but timing and amount must integrate the absolute concentrations, ongoing catabolic state, and the need to avoid essential-amino-acid deprivation.
Takeaway. Temporary crisis restriction should transition to measured essential-amino-acid intake when serial concentrations and clinical status support it; a falling value alone is not a universal restart trigger.
Which measured reaction is preserved, and which is impaired?
Show answer and explanations for case 21
A. Pyridoxal phosphate for BCAT transamination (Why this does not fit)
What makes this option worth considering?
BCAT indeed requires vitamin B6-derived PLP.
What does the paired evidence add?
the leucine-to-KIC step is preserved while KIC oxidation is poor
Complete explanation
BCAT indeed requires vitamin B6-derived PLP. The supplied evidence instead shows that the leucine-to-KIC step is preserved while KIC oxidation is poor.
B. Thiamine pyrophosphate for BCKD oxidative decarboxylation (Best answer)
What makes this option worth considering?
TPP participates in BCKD E1 ketoacid decarboxylation.
What does the paired evidence add?
the measured defect is oxidation of KIC, not its formation.
Complete explanation
TPP participates in BCKD E1 ketoacid decarboxylation. The supplied evidence favors this answer. the measured defect is oxidation of KIC, not its formation; any response must be measured rather than assumed.
C. Thiamine pyrophosphate for BCAT transamination (Why this does not fit)
What makes this option worth considering?
Thiamine is relevant to branched-chain metabolism.
What does the paired evidence add?
bCAT is the preserved PLP-dependent step, not a TPP-dependent transaminase
Complete explanation
Thiamine is relevant to branched-chain metabolism. The supplied evidence instead shows that bCAT is the preserved PLP-dependent step, not a TPP-dependent transaminase.
D. Pyridoxal phosphate for BCKD oxidative decarboxylation (Why this does not fit)
What makes this option worth considering?
PLP works in amino-acid metabolism.
What does the paired evidence add?
the impaired oxidative step requires the BCKD cofactor set, including TPP, not PLP as its E1 cofactor
Complete explanation
PLP works in amino-acid metabolism. The supplied evidence instead shows that the impaired oxidative step requires the BCKD cofactor set, including TPP, not PLP as its E1 cofactor.
E. Biotin for BCKD oxidative decarboxylation (Why this does not fit)
What makes this option worth considering?
Biotin supports several carboxylases.
What does the paired evidence add?
the measured reaction removes CO2 from KIC rather than adding CO2 by carboxylation
Complete explanation
Biotin supports several carboxylases. The supplied evidence instead shows that the measured reaction removes CO2 from KIC rather than adding CO2 by carboxylation.
Takeaway. Normal KIC formation demonstrates retained PLP-dependent BCAT flux. Impaired KIC oxidation localizes downstream to BCKD, whose E1 uses thiamine pyrophosphate; responsiveness cannot be inferred from this assay alone.
Predict each other complex’s activity if the common component is impaired.
Show answer and explanations for case 22
A. Low pyruvate oxidation with preserved alpha-ketoglutarate oxidation (Why this does not fit)
What makes this option worth considering?
The lactate elevation could reflect PDH impairment.
What does the paired evidence add?
But an isolated PDH deficit does not show the predicted shared E3 effect on alpha-KGDH
Complete explanation
The lactate elevation could reflect PDH impairment, but an isolated PDH deficit does not show the predicted shared E3 effect on alpha-KGDH.
B. Preserved pyruvate oxidation with low alpha-ketoglutarate oxidation (Why this does not fit)
What makes this option worth considering?
Alpha-KGDH can be affected by E3 loss.
What does the paired evidence add?
But preserved PDH activity would not fit a broad shared-component deficit as well
Complete explanation
Alpha-KGDH can be affected by E3 loss, but preserved PDH activity would not fit a broad shared-component deficit as well.
C. Preserved oxidation of both pyruvate and alpha-ketoglutarate (Why this does not fit)
What makes this option worth considering?
Preserved activity in both assays would favor a BCKD-specific lesion.
What does the paired evidence add?
It would not explain the lactate through shared E3 impairment
Complete explanation
Preserved activity in both assays would favor a BCKD-specific lesion. It would not explain the lactate through shared E3 impairment.
D. Low oxidation of both pyruvate and alpha-ketoglutarate (Best answer)
What makes this option worth considering?
E3 participates in BCKD, PDH and alpha-KGDH.
What does the paired evidence add?
Deficits with each separate substrate would extend the known BCKD defect to both other complexes and help explain lactate elevation
Complete explanation
E3 participates in BCKD, PDH and alpha-KGDH. Deficits with each separate substrate would extend the known BCKD defect to both other complexes and help explain lactate elevation.
E. Increased oxidation of both pyruvate and alpha-ketoglutarate (Why this does not fit)
What makes this option worth considering?
Both other complexes use E3.
What does the paired evidence add?
Increased activities would not support a shared loss that explains persistent lactate
Complete explanation
Both other complexes use E3. Increased activities would not support a shared loss that explains persistent lactate.
Takeaway. A BCKD-specific subunit defect need not impair PDH or alpha-KGDH; shared DLD/E3 dysfunction predicts reduced activity in both additional oxidative complexes.
Compare the final value with the interval, then interpret the persistent CNS findings.
Show answer and explanations for case 23
A. Plasma leucine reduction rules out continuing metabolic exposure (Why this does not fit)
What makes this option worth considering?
The fall documents biochemical improvement.
What does the paired evidence add?
The final 320 µmol/L remains above the stated upper interval and does not exclude ongoing exposure
Complete explanation
The fall documents biochemical improvement. The final 320 µmol/L remains above the stated upper interval and does not exclude ongoing exposure.
B. Persistent ataxia establishes that treatment had no biochemical effect (Why this does not fit)
What makes this option worth considering?
Clinical recovery is an important endpoint.
What does the paired evidence add?
The measured leucine fall shows a biochemical effect even though neurologic findings persist
Complete explanation
Clinical recovery is an important endpoint. The measured leucine fall shows a biochemical effect even though neurologic findings persist.
C. KIC and cerebral injury may persist or recover on a different time course than plasma leucine (Best answer)
What makes this option worth considering?
Plasma leucine fell substantially but remains above the supplied interval.
What does the paired evidence add?
Persistent neurologic findings need not resolve on the same time course.
Complete explanation
Plasma leucine fell substantially but remains above the supplied interval. Persistent neurologic findings need not resolve on the same time course; KIC or prior CNS injury may contribute, though KIC kinetics were not measured.
D. Persistent ataxia establishes a separate unrelated neurologic disorder (Why this does not fit)
What makes this option worth considering?
Other causes deserve evaluation when findings persist.
What does the paired evidence add?
The known crisis and residual elevation leave metabolic injury or ongoing exposure plausible
Complete explanation
Other causes deserve evaluation when findings persist. The known crisis and residual elevation leave metabolic injury or ongoing exposure plausible.
E. The MRI findings prove that circulating KIC rose after treatment (Why this does not fit)
What makes this option worth considering?
KIC can contribute to injury.
What does the paired evidence add?
No serial KIC values were supplied, so imaging cannot establish its direction after treatment
Complete explanation
KIC can contribute to injury. No serial KIC values were supplied, so imaging cannot establish its direction after treatment.
Takeaway. The reduced plasma leucine is still elevated; persistent CNS findings may reflect ongoing exposure or injury with a different recovery course. KIC kinetics are not measured here.
Subtract input and removal after nutrition, then add the proposed removal route.
Show answer and explanations for case 24
A. Nutrition alone gives +10; added clearance gives −15 units per interval (Best answer)
What makes this option worth considering?
After nutrition, 50 minus 40 remains positive.
What does the paired evidence add?
Adding 25 removal units makes removal 65, so 50 minus 65 is negative.
Complete explanation
After nutrition, 50 minus 40 remains positive. Adding 25 removal units makes removal 65, so 50 minus 65 is negative; the modeled pool would then fall.
B. Nutrition alone gives −10; added clearance gives −35 units per interval (Why this does not fit)
What makes this option worth considering?
The input reduction is substantial.
What does the paired evidence add?
But 50 minus 40 is still +10, not a falling pool before clearance
Complete explanation
The input reduction is substantial, but 50 minus 40 is still +10, not a falling pool before clearance.
C. Nutrition alone gives +10; added clearance gives +35 units per interval (Why this does not fit)
What makes this option worth considering?
The first balance is correct.
What does the paired evidence add?
But adding removal subtracts 25 from net balance rather than adding it
Complete explanation
The first balance is correct, but adding removal subtracts 25 from net balance rather than adding it.
D. Nutrition alone gives +80; added clearance gives +55 units per interval (Why this does not fit)
What makes this option worth considering?
The earlier input was 120 units.
What does the paired evidence add?
The post-nutrition input is 50, so retaining the old balance misses the intervention
Complete explanation
The earlier input was 120 units. The post-nutrition input is 50, so retaining the old balance misses the intervention.
E. Nutrition alone gives zero; added clearance gives −25 units per interval (Why this does not fit)
What makes this option worth considering?
The post-nutrition input remains 50 units.
What does the paired evidence add?
It exceeds the existing 40-unit removal, so the initial balance cannot be zero
Complete explanation
The post-nutrition input remains 50 units. It exceeds the existing 40-unit removal, so the initial balance cannot be zero.
Takeaway. Input minus removal is +10 after nutrition and −15 with the illustrative added clearance. A falling pool requires removal to exceed continuing input; this model supplies no clinical dosing threshold.
Use nitrogen loss to infer endogenous input, then ask whether this intervention removes circulating solute.
Show answer and explanations for case 25
A. Lower proteolysis and higher protein synthesis, without direct solute removal (Best answer)
What makes this option worth considering?
The nitrogen loss suggests ongoing catabolism despite calories.
What does the paired evidence add?
Insulin can support incorporation and reduce endogenous BCAA release with monitored energy and substrates.
Complete explanation
The nitrogen loss suggests ongoing catabolism despite calories. Insulin can support incorporation and reduce endogenous BCAA release with monitored energy and substrates, but it does not directly clear circulating leucine.
B. Higher proteolysis and higher protein synthesis, with direct solute removal (Why this does not fit)
What makes this option worth considering?
Anabolism may improve.
What does the paired evidence add?
But stimulating breakdown would worsen endogenous leucine input.
Complete explanation
Anabolism may improve, but stimulating breakdown would worsen endogenous leucine input; insulin is not extracorporeal clearance.
C. Lower proteolysis and lower protein synthesis, with direct solute removal (Why this does not fit)
What makes this option worth considering?
Lower breakdown is a goal.
What does the paired evidence add?
But impaired synthesis leaves fewer routes to incorporate amino acids, and insulin does not directly remove the pool
Complete explanation
Lower breakdown is a goal, but impaired synthesis leaves fewer routes to incorporate amino acids, and insulin does not directly remove the pool.
D. Higher BCKD oxidation and lower proteolysis, without amino-acid need (Why this does not fit)
What makes this option worth considering?
Insulin may restrain catabolism.
What does the paired evidence add?
But it does not repair the BCKD enzyme or remove the essential requirement for balanced amino acids
Complete explanation
Insulin may restrain catabolism, but it does not repair the BCKD enzyme or remove the essential requirement for balanced amino acids.
E. Lower glucose delivery and higher renal leucine excretion, without anabolism (Why this does not fit)
What makes this option worth considering?
Rising glucose needs monitoring, not automatic withdrawal of necessary calories.
What does the paired evidence add?
The treatment's intended mechanism is anabolic rather than renal clearance
Complete explanation
Rising glucose needs monitoring, not automatic withdrawal of necessary calories. The treatment's intended mechanism is anabolic rather than renal clearance.
Takeaway. With continuing energy, amino acids and glucose/electrolyte monitoring, insulin can help suppress proteolysis and support synthesis. It does not replace BCKD or direct clearance.
